The Prostate Cancer Charity welcomes NICE’s draft denosumab ruling30 Mar 2012 TheProstate Cancer Charity has welcomed the National Institute for Health and Clinical Excellence's (NICE) draft decision to recommend that denosumab be made available for men with advanced prostate cancer which has spread to the bone on the NHS throughout the UK. Read more
Abiraterone letter to editor15 Mar 2012 Dear Sir, March is Prostate Cancer Awareness Month. In a few weeks time NICE will meet to discuss the responses to their draft decision not to recommend abiraterone, a life extending drug for men with incurable prostate cancer. Read more
Charity warns “short sighted” NICE risks compromising care of men with prostate cancer14 Mar 2012 Men with prostate cancer are at risk of being left behind those with other common cancers thanks to a spate of recent moves by the National Institute for Health and Clinical Excellence (NICE), The Prostate Cancer Charity has warned. Read more
The Prostate Cancer Charity comments on a new study examining prostate cancer screening31 Mar 2011 The Prostate Cancer Charity comments on new research, published in British Medical Journal, which examines the impact of prostate cancer screening on mortality. Read more